$1.25

0.04 (3.31%)
Live
Previous Close

$1.21

Day Range

$0 - $0

Previous Day Range

$1.1603 - $1.23

Market Cap

$745.2 million USD

Day Vol.

0

Previous Day Vol.

14.0 million

Currency

USD

Primary Exchange

Nasdaq

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Geron Corporation (GERN) is facing a securities fraud lawsuit for allegedly making false and misleading statements about its drug Rytelo's launch and potential growth, leading to investor losses.

Related tickers: GERN.

Read Full Article

Faruqi & Faruqi, LLP is investigating potential claims against Geron Corporation (GERN) for making false and/or misleading statements about its drug Rytelo. The company's stock price declined significantly after it announced that Rytelo's growth had flattened due to seasonality, competition, lack of awareness, and the burden of the monitoring requirement.

Related tickers: GERN.

Read Full Article
Trending Tickers

Please sign in to view